Changes in Utilization of Generic Angiotensin Receptor Blockers Following Product Recalls in the United States.
Where this comes from
- Record sourced from PubMed, PMID 31910271.
- Also identified by DOI 10.1001/jama.2019.17521 and PMC identifier PMC7066505.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This pharmacoepidemiology study uses claims data to characterize angiotensin receptor blocker (ARB) prescription trends to evaluate whether recalls of ARBs prompted by discovery of potentially carcinogenic impurities shifted utilization of ARBs individually and as a drug class.